Insider Trading & Ownership - Verve Therapeutics Inc. (VERV)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Verve Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-01
Purchase
2023-12-05
4:30 pm
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
1,800,000$10$18,000,00012,168,489
(Indirect)
View
2023-11-29
Sale
2023-12-01
4:30 pm
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
554$11.45$6,3437,810
(Direct)
View
2022-12-01
Sale
2022-12-02
5:00 pm
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
865$22.95$19,8526,629
(Direct)
View
2022-11-29
Sale
2022-12-01
5:00 pm
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
554$22.1$12,2437,811
(Direct)
View
2022-11-04
Sale
2022-11-08
5:51 pm
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
48,583$31.14$1,512,8064,308,630
(Indirect)
View
2022-11-04
Sale
2022-11-08
5:04 pm
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
97,166$31.14$3,025,6114,308,630
(Indirect)
View
2022-11-02
Sale
2022-11-04
5:58 pm
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
78,220$33.95$2,655,3304,386,850
(Indirect)
View
2022-11-02
Sale
2022-11-04
4:16 pm
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
156,440$33.95$5,310,6584,386,850
(Indirect)
View
2022-10-31
Sale
2022-11-02
9:02 pm
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
85,659$37.95$3,250,4964,472,510
(Indirect)
View
2022-10-31
Sale
2022-11-02
4:25 pm
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
171,319$37.95$6,501,0314,472,510
(Indirect)
View
2022-10-28
Sale
2022-11-01
5:00 pm
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
10,000$39.9$399,00093,624
(Direct)
View
2022-10-03
Sale
2022-10-05
5:00 pm
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$33.65$1,682,622778,828
(Indirect
Direct)
View
2022-09-23
Sale
2022-09-27
5:00 pm
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
60,000$35.34$2,120,392126,822
(Direct)
View
2022-08-10
Sale
2022-08-11
5:00 pm
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$29.9$1,495,000807,258
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
186,000$0186,000
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
658,000$0658,000
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVNickerson Joan
Chief Administrative Officer
149,000$0149,000
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVFiedorek Fred T.
Chief Medical Officer
112,000$0112,000
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
225,000$0225,000
(Direct)
View
2024-02-14
Option Award
2024-02-16
4:30 pm
N/A
2034-02-13
Verve Therapeutics Inc.VERVBellinger Andrew
Chief Scientific Officer
225,000$0225,000
(Direct)
View
2022-11-07
Ownership
2024-02-09
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVADELMAN BURT A
Director
409,626$0428,326
(Indirect)
View

Ownership
2023-12-05
4:50 pm
N/A
N/A
Verve Therapeutics Inc.VERVGV 2023 GP L.L.C.
GV 2023 GP L.P.
GV 2023 L.P.
Alphabet Inc.
Member of 10% Group
0$01,800,000
(Indirect)
View
2023-11-29
Exercise
2023-12-01
4:30 pm
N/A
N/A
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
1,875$07,810
(Direct)
View
2023-09-18
Option Award
2023-09-19
5:05 pm
N/A
2033-09-17
Verve Therapeutics Inc.VERVFiedorek Fred T.
Chief Medical Officer
180,000$0180,000
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVMacLean Michael F
Director
26,642$026,642
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVCumbo Alexander
Director
26,642$026,642
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
26,642$026,642
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVADELMAN BURT A
Director
26,642$026,642
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVCOATS LONNEL
Director
26,642$026,642
(Direct)
View
2023-06-15
Option Award
2023-06-20
5:00 pm
N/A
2033-06-14
Verve Therapeutics Inc.VERVMikhail Sheila
Director
26,642$026,642
(Direct)
View

Ownership
2023-02-23
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVNickerson Joan
Chief Administrative Officer
0$0242,940
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
182,800$0182,800
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
182,800$0182,800
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
550,200$0550,200
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVMacLean Michael F
Director
7,000$07,000
(Direct)
View
2023-02-14
Option Award
2023-02-16
5:00 pm
N/A
2033-02-13
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
182,800$0182,800
(Direct)
View
2022-12-14
Exercise
2022-12-16
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
36,000$2.87222,623
(Direct)
View
2022-12-14
Exercise
2022-12-16
5:00 pm
N/A
2030-09-15
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
36,000$0222,623
(Direct)
View
2022-11-29
Exercise
2022-12-01
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVDorval Allison
Chief Financial Officer
1,875$07,811
(Direct)
View
2022-11-04
Other
2022-11-08
5:51 pm
N/A
N/A
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
48,583$04,308,630
(Indirect)
View
2022-11-04
Other
2022-11-08
5:04 pm
N/A
N/A
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
48,583$04,308,630
(Indirect)
View
2022-11-02
Other
2022-11-04
5:58 pm
N/A
N/A
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
78,220$04,386,850
(Indirect)
View
2022-11-02
Other
2022-11-04
4:16 pm
N/A
N/A
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
78,220$04,386,850
(Indirect)
View
2022-10-31
Other
2022-11-02
9:02 pm
N/A
N/A
Verve Therapeutics Inc.VERVYeshwant Krishna
Director
10% Owner
85,660$04,472,510
(Indirect)
View
2022-10-31
Other
2022-11-02
4:25 pm
N/A
N/A
Verve Therapeutics Inc.VERVGV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
85,660$04,472,510
(Indirect)
View
2022-10-28
Exercise
2022-11-01
5:00 pm
N/A
2029-09-16
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
10,000$093,624
(Direct)
View
2022-10-28
Exercise
2022-11-01
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
10,000$1.4893,624
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:00 pm
N/A
2029-04-14
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$0778,828
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$1.39778,828
(Direct)
View
2022-09-23
Exercise
2022-09-27
5:00 pm
N/A
2029-09-16
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
60,000$0126,822
(Direct)
View
2022-09-23
Exercise
2022-09-27
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVBellinger Andrew
CSO & CMO
60,000$1.48126,822
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
10,835$2.87446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
2028-11-07
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
95,787$0446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
51,203$1.39446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVAshe Andrew D.
See Remarks
33,749$1.48446,786
(Direct)
View
2022-08-10
Exercise
2022-08-11
5:00 pm
N/A
2029-04-14
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$0807,258
(Direct)
View
2022-08-10
Exercise
2022-08-11
5:00 pm
N/A
N/A
Verve Therapeutics Inc.VERVKathiresan Sekar
Chief Executive Officer
50,000$1.39807,258
(Direct)
View
2022-08-08
Option Award
2022-08-09
5:05 pm
N/A
2032-08-07
Verve Therapeutics Inc.VERVCOATS LONNEL
Director
31,000$031,000
(Direct)
View
Goto 0, 1, 2, 3, Next